111 related articles for article (PubMed ID: 17700068)
1. p18(Hamlet) mediates different p53-dependent responses to DNA-damage inducing agents.
Lafarga V; Cuadrado A; Nebreda AR
Cell Cycle; 2007 Oct; 6(19):2319-22. PubMed ID: 17700068
[TBL] [Abstract][Full Text] [Related]
2. A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis.
Cuadrado A; Lafarga V; Cheung PC; Dolado I; Llanos S; Cohen P; Nebreda AR
EMBO J; 2007 Apr; 26(8):2115-26. PubMed ID: 17380123
[TBL] [Abstract][Full Text] [Related]
3. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
4. Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis.
Wang J; Thomas HR; Li Z; Yeo NCF; Scott HE; Dang N; Hossain MI; Andrabi SA; Parant JM
Cell Death Dis; 2021 Jun; 12(7):659. PubMed ID: 34193827
[TBL] [Abstract][Full Text] [Related]
5. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes.
Hill R; Leidal AM; Madureira PA; Gillis LD; Waisman DM; Chiu A; Lee PW
DNA Repair (Amst); 2008 Sep; 7(9):1484-99. PubMed ID: 18602874
[TBL] [Abstract][Full Text] [Related]
6. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
7. p53 Binding to the p21 promoter is dependent on the nature of DNA damage.
Hill R; Bodzak E; Blough MD; Lee PW
Cell Cycle; 2008 Aug; 7(16):2535-43. PubMed ID: 18719376
[TBL] [Abstract][Full Text] [Related]
8. Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence.
Tavana O; Benjamin CL; Puebla-Osorio N; Sang M; Ullrich SE; Ananthaswamy HN; Zhu C
Cell Cycle; 2010 Aug; 9(16):3328-36. PubMed ID: 20703098
[TBL] [Abstract][Full Text] [Related]
9. Teratogen-induced activation of p53 in early postimplantation mouse embryos.
Hosako H; Little SA; Barrier M; Mirkes PE
Toxicol Sci; 2007 Jan; 95(1):257-69. PubMed ID: 17068108
[TBL] [Abstract][Full Text] [Related]
10. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
11. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
12. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
13. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
[TBL] [Abstract][Full Text] [Related]
14. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
15. Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
Guadagno J; Swan P; Shaikh R; Cregan SP
Cell Death Dis; 2015 Jun; 6(6):e1779. PubMed ID: 26043079
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21.
Leibowitz BJ; Qiu W; Liu H; Cheng T; Zhang L; Yu J
Mol Cancer Res; 2011 May; 9(5):616-25. PubMed ID: 21450905
[TBL] [Abstract][Full Text] [Related]
17. SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing.
Chen Y; Zhang L; Jones KA
Genes Dev; 2011 Apr; 25(7):701-16. PubMed ID: 21460037
[TBL] [Abstract][Full Text] [Related]
18. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
[TBL] [Abstract][Full Text] [Related]
20. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
Michod D; Widmann C
Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
